Legend Biotech Corp Sustainability Reports

Legend Biotech Corporation is a global clinical-stage biopharmaceutical company focused on discovering and developing novel cell therapies for oncology and other indications. The company is best known for developing CARVYKTI, a CAR-T cell therapy for relapsed or refractory multiple myeloma.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 254900EIUFZTW136H859

FIGI: BBG00TTGH6N2

3 reports from 2023 to 2025

• Legend Biotech Corp 2025 Environmental, Social, and Governance Report
• Legend Biotech Corp 2024 Environmental, Social, and Governance Report
• Legend Biotech Corp 2023 Environmental, Social, and Governance Report